Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism
Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update
Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism
Cartier Cuts 7.9 g/t Au Over 4.0 m Within A Broader Segment of 2.3 g/t Au Over 19.0 m at Hope Sector ; Unlocks New High-Grade Gold Zone in Underexplored Pontiac Sediments
CHARBONE annonce la signature d'un contrat d'approvisionnement de trois ans en oxygene UHP avec un client strategique americain, renforcant sa presence aux Etats-Unis
CHARBONE Announces the Signing of a Three-year UHP Oxygen Supply Contract with a Strategic American Customer, Strengthening its Presence in the United States
